Cliical Trials: Journal Policies & Preprints

Integrating Journal Policies & Preprints With Data Privacy, GDPR and HIPAA Requirements The integration of journal policies and preprints with data privacy frameworks, particularly the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA), presents intricate challenges and opportunities in the realm of translational clinical research. This guide provides a…

Read More “Integrating Journal Policies & Preprints With Data Privacy, GDPR and HIPAA Requirements” »

Case Studies: Journal Policies & Preprints That Strengthened Public and Regulator Trust In the landscape of clinical research trials, trust plays a pivotal role in ensuring the integrity of the process and the reliability of outcomes. This tutorial guide aims to present a series of case studies focusing on journal policies and preprints, demonstrating their…

Read More “Case Studies: Journal Policies & Preprints That Strengthened Public and Regulator Trust” »

Training Clinical, Regulatory and Medical Teams on Journal Policies & Preprints Training Clinical, Regulatory and Medical Teams on Journal Policies & Preprints Introduction to Journal Policies and Preprints in Clinical Trials The landscape of clinical trials is continually evolving, requiring clinical, regulatory, and medical affairs professionals to stay informed about the latest in journal policies…

Read More “Training Clinical, Regulatory and Medical Teams on Journal Policies & Preprints” »

Vendor and Partner Oversight Considerations for Journal Policies & Preprints Vendor and Partner Oversight Considerations for Journal Policies & Preprints Introduction to Regulatory Publishing in Clinical Trials In the contemporary landscape of clinical research, ensuring transparency and compliance is crucial. Regulatory publishing has become an essential facet of clinical trials, particularly related to the dissemination…

Read More “Vendor and Partner Oversight Considerations for Journal Policies & Preprints” »

Future Trends: AI, Real-World Data and Evolving Rules for Journal Policies & Preprints Future Trends: AI, Real-World Data and Evolving Rules for Journal Policies & Preprints In the evolving landscape of clinical research, understanding the intersection of artificial intelligence (AI), real-world data (RWD), and journal publication policies is paramount for clinical operations, regulatory affairs, and…

Read More “Future Trends: AI, Real-World Data and Evolving Rules for Journal Policies & Preprints” »

Using Journal Policies & Preprints to Support Publications, HTA and Market Access Using Journal Policies & Preprints to Support Publications, HTA and Market Access The integration of real-world evidence (RWE) into clinical development and the dissemination of research findings play a pivotal role in the regulatory landscape, particularly concerning Health Technology Assessment (HTA) and market…

Read More “Using Journal Policies & Preprints to Support Publications, HTA and Market Access” »